Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.85 $3.19 Wednesday, 8th May 2024 ATHE stock ended at $2.04. This is 2.86% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 9.31% from a day low at $2.04 to a day high of $2.23.
90 days $1.55 $3.19
52 weeks $1.55 $5.41

Historical Alterity Therapeutics Limited prices

Date Open High Low Close Volume
Jan 22, 2024 $1.88 $1.94 $1.84 $1.85 32 734
Jan 19, 2024 $1.86 $1.94 $1.85 $1.86 21 377
Jan 18, 2024 $1.85 $1.98 $1.85 $1.88 24 149
Jan 17, 2024 $1.88 $2.14 $1.83 $1.89 38 461
Jan 16, 2024 $1.90 $2.10 $1.80 $1.87 67 462
Jan 12, 2024 $1.90 $2.08 $1.85 $1.90 85 653
Jan 11, 2024 $1.84 $1.98 $1.84 $1.89 7 908
Jan 10, 2024 $1.87 $2.00 $1.87 $1.90 18 455
Jan 09, 2024 $2.06 $2.06 $1.94 $1.96 59 736
Jan 08, 2024 $1.99 $2.17 $1.90 $2.02 119 067
Jan 05, 2024 $2.25 $2.25 $2.08 $2.14 114 298
Jan 04, 2024 $2.42 $2.46 $2.25 $2.36 82 689
Jan 03, 2024 $2.58 $2.58 $2.41 $2.48 39 271
Jan 02, 2024 $2.58 $2.59 $2.40 $2.48 29 271
Dec 29, 2023 $2.49 $2.57 $2.44 $2.49 15 701
Dec 28, 2023 $2.58 $2.58 $2.41 $2.47 21 364
Dec 27, 2023 $2.53 $2.65 $2.43 $2.57 122 554
Dec 26, 2023 $2.62 $2.65 $2.47 $2.54 42 565
Dec 22, 2023 $2.55 $2.72 $2.39 $2.67 30 982
Dec 21, 2023 $2.63 $2.76 $2.52 $2.60 36 517
Dec 20, 2023 $2.79 $2.79 $2.63 $2.66 18 410
Dec 19, 2023 $2.86 $2.93 $2.53 $2.69 65 995
Dec 18, 2023 $3.19 $3.19 $2.87 $2.90 86 749
Dec 15, 2023 $2.99 $3.09 $2.94 $3.03 74 422
Dec 14, 2023 $2.82 $3.25 $2.80 $3.05 238 304
Click to get the best stock tips daily for free!

About Alterity Therapeutics Limited

Alterity Therapeutics Limited Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company ... ATHE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT